News

Researchers have unlocked secrets of our ancient immune system, a major scientific advance which could help scientists and clinicians in the global fight against disease. An international team, including researchers from The University of Queensland, identified interactions between immune system pathways which could improve the treatment of diseases such as inflammatory bowel disease (IBD), which affects millions of people worldwide.

IMB staff have been recognised for their outstanding contributions to the UQ community at the 2016 UQ Awards for Excellence ceremony, held on 9 June.

IMB Research Grants Manager Michelle Foley received a UQ Award for Excellence in Service, and IMB’s Community for Antimicrobial Drug Discovery (CO-ADD) team received a UQ Award for Excellence in Innovation.

IMB Group Leader Dr Joseph Powell has been awarded the prestigious Commonwealth Health Minister’s Award for Excellence in Health and Medical Research.

Queensland researchers have made a big leap forward in their quest to eradicate the billions of cane toads wreaking havoc on our native wildlife and habitats.

Environmentally friendly cane toad traps – developed by a team of researchers from The University of Queensland and The University of Sydney – are one step closer to production, following an agreement between UQ and US-based pest control company, SpringStar Inc.

Spiders have helped researchers from Australia and the US discover a new target for irritable bowel syndrome pain.

Taking medicine in the future could be as simple as eating a sunflower seed or drinking a cup of tea made from herbs grown in your own garden.

An international team involving University of Queensland researchers has used advanced genome sequencing to diagnose 30 patients with unresolved rare diseases.

UQ’s Community for Open Antimicrobial Drug Discovery (CO-ADD) has signed a Memorandum of Understanding (MOU) with the African Network for Drugs and Diagnostics Innovation (ANDI) which is hosted by the United Nations Office for Project Services (UNOPS).

Researchers from The University of Queensland (UQ) are advancing their mission to discover new antibiotics capable of combating multi-drug resistant bacterial infections after signing an agreement to screen the entire French National Chemical Library.

IMB recently launched its new Queensland Facility for Advanced Genome Editing (QFAGE), based at UQ's St Lucia campus, which provides expert genetic modification services using CRISPR/Cas9 genome editing technology in mice.

Researchers from The University of Queensland have identified a treatment target for aggressive forms of breast cancer.

CO2 emissions and thus global warming could rise more quickly than expected, according to a new model by University of Queensland and Griffith University researchers.

This year on Rare Disease Day, Associate Professor Carol Wicking, Director of the IMB Centre for Rare Diseases Research, explains what rare diseases are and why a co-ordinated approach to tackling rare diseases is needed.

An international team led by Australian researchers has studied the genetics of pancreatic cancer, revealing it is actually four separate diseases, each with different genetic triggers and survival rates, paving the way for more accurate diagnoses and treatments.

IMB is home to some of the world’s most influential scientific minds, measured by Thomson Reuters Highly Cited Researchers index. New group leader Professor Grant Montgomery was named in this prestigious index.